[HTML][HTML] Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

S Dispinseri, M Secchi, MF Pirillo, M Tolazzi… - Nature …, 2021 - nature.com
Understanding how antibody responses to SARS-CoV-2 evolve during infection may provide
important insight into therapeutic approaches and vaccination for COVID-19. Here we …

[HTML][HTML] Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence

…, A Sarkar, PJM Brouwer, Y Hua, M Tolazzi… - Nature …, 2019 - nature.com
Stabilized HIV-1 envelope glycoproteins (Env) that resemble the native Env are utilized in
vaccination strategies aimed at inducing broadly neutralizing antibodies (bNAbs). To limit the …

α-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4

L Furci, F Sironi, M Tolazzi, L Vassena, P Lusso - Blood, 2007 - ashpublications.org
α-defensins are antibiotic peptides that act as natural inhibitors of HIV-1 infection. However,
the mechanisms of such inhibition are still unclear. Here we demonstrate that α-defensins …

[PDF][PDF] Rational design of DNA-expressed stabilized native-like HIV-1 envelope trimers

…, PF McKay, J Allen, G Ozorowski, RF Lévai, M Tolazzi… - Cell reports, 2018 - cell.com
The HIV-1-envelope glycoprotein (Env) is the main target of antigen design for antibody-based
prophylactic vaccines. The generation of broadly neutralizing antibodies (bNAb) likely …

[HTML][HTML] Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers

…, RF Lévai, P Mundsperger, PJM Brouwer, M Tolazzi… - npj Vaccines, 2021 - nature.com
The immunogenicity of HIV-1 envelope (Env) trimers is generally poor. We used the
clinically relevant ConM SOSIP trimer to compare the ability of different adjuvants (squalene …

[HTML][HTML] International network for comparison of HIV neutralization assays: the NeutNet report II

…, V Polonis, M Ramaswamy, Q Sattentau, M Tolazzi… - PloS one, 2012 - journals.plos.org
Background Neutralizing antibodies provide markers for vaccine-induced protective
immunity in many viral infections. By analogy, HIV-1 neutralizing antibodies induced by …

[HTML][HTML] Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae

L Furci, M Tolazzi, F Sironi, L Vassena, P Lusso - 2012 - journals.plos.org
Background α-defensin-5 (HD5) is a key effector of the innate immune system with broad
anti-bacterial and anti-viral activities. Specialized epithelial cells secrete HD5 in the genital and …

[HTML][HTML] Seasonal betacoronavirus antibodies' expansion post-BNT161b2 vaccination associates with reduced SARS-CoV-2 VoC neutralization

…, I Marzinotto, C Brigatti, MF Pirillo, M Tolazzi… - Journal of Clinical …, 2022 - Springer
SARS-CoV-2 vaccination is known to induce antibodies that recognize also variants of
concerns (VoCs) of the virus. However, epidemiological and laboratory evidences indicate that …

Superior efficacy of a human immunodeficiency virus vaccine combined with antiretroviral prevention in simian-human immunodeficiency virus-challenged nonhuman …

…, L Gosse, D Desjardins, X Shen, M Tolazzi… - Journal of …, 2016 - Am Soc Microbiol
Although vaccines and antiretroviral (ARV) prevention have demonstrated partial success
against human immunodeficiency virus (HIV) infection in clinical trials, their combined …

Combined skin and muscle DNA priming provides enhanced humoral responses to a human immunodeficency virus type 1 clade C envelope vaccine

…, A Cope, D Cizmeci, M Tolazzi… - Human gene …, 2018 - liebertpub.com
Intradermal (id) and intramuscular (im) injections when administered with or without
electroporation (EP) have the potential to tailor the immune response to DNA vaccination. This …